Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

Eliezer M. Van Allen(Broad Institute), Levi A. Garraway(Broad Institute), Judy E. Garber(Dana-Farber Cancer Institute), Judit Jané‐Valbuena(Broad Institute), Steven Joffe(California University of Pennsylvania), Stacy W. Gray(Dana-Farber Cancer Institute), Petar Stojanov(Broad Institute), Douglas Voet(Broad Institute), Adam Kieżun(Broad Institute), Leena Gandhi(Dana-Farber Cancer Institute), Eric S. Lander(Broad Institute), Scott L. Carter(Broad Institute), Neal I. Lindeman(Cornell University), Jeff Gentry(Broad Institute), Jennifer Fostel(Broad Institute), Andrey Sivachenko(Broad Institute), Aaron McKenna(Dartmouth College), Pasi A. Jänne(Beth Israel Deaconess Medical Center), Mara Rosenberg(Broad Institute), Kristian Cibulskis(Broad Institute), Philip W. Kantoff(Unknown), Gregory V. Kryukov(Broad Institute), David A. Barbie(Dana-Farber Cancer Institute), Stacey Gabriel(Broad Institute), Danielle Perrin(Broad Institute), Deborah Farlow(Broad Institute), Nikhil Wagle(Broad Institute), Michael S. Lawrence(Broad Institute), Franklin W. Huang(San Francisco VA Medical Center), Laura E. MacConaill(Brigham and Women's Hospital), Barrett J. Rollins(Harvard University), Lee Lichtenstein(Broad Institute), Dennis C. Friedrich(Broad Institute), Gad Getz(Broad Institute), Sara Marlow(Broad Institute), Sheila Fisher(Broad Institute)
Nature Medicine
May 18, 2014
Cited by 571


Related Papers